Progyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
Follow PGNY
Alert me
Progyny, Inc. (PGNY) Net income
Progyny, Inc.'s net income for fiscal 2025 was $58.5M, up 7.70% from $54.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $91.0M. Over the past ten years it has ranged from −$12.5M (fiscal 2017) to $65.8M (fiscal 2021); the current reading is higher than 78% of that period. Progyny, Inc. ranks 8th of 12 Healthcare Plans companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $58.5M | 7.70% |
| FY2024 | $54.3M | (12.41%) |
| FY2023 | $62.0M | 104.35% |
| FY2022 | $30.4M | (53.84%) |
| FY2021 | $65.8M | 41.56% |
| FY2020 | $46.5M | — |
| FY2019 | −$8.6M | — |
| FY2018 | $661.0K | — |
| FY2017 | −$12.5M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $26.3M | (6.42%) |
| Jun 2026 | $28.1M | 15.76% |
| Mar 2026 | $24.2M | 94.09% |
| Dec 2025 | $12.5M | (9.95%) |
| 31 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| CI Cigna Group compare | $6.7B |
| ELV Elevance Health, Inc. compare | $5.1B |
| CNC Centene Corporation compare | $1.5B |
| HUM Humana Inc. compare | $1.3B |
| OSCR Oscar Health, Inc. compare | $855.7M |
| PGNY Progyny, Inc. | $91.0M |
| ALHC Alignment Healthcare, Inc. compare | $28.9M |
| CLOV Clover Health Investments, Corp. compare | $12.5M |
| MOH Molina Healthcare, Inc compare | −$48.0M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on PGNY
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement